The ISET Test (Isolation by SizE of Tumor cells / Trophoblastic cells) is a diagnostic blood test that detects circulating tumor cells in a blood sample.<ref>[http://www.futura-sciences.com/magazines/sante/infos/actu/d/medecine-iset-prise-sang-precoce-depister-maladies-genetiques-43349/ "ISET : une prise de sang précoce pour dépister des maladies génétiques] par Inserm dans Futura Santé du 13 décembre 2012.</ref>"Cancer : une nouvelle méthode pronostique non invasive testée sur le cancer du foie" par INSERM dans Caducee.net du12 mai 2004. The test uses an in-vitro diagnostic system developed at INSERM, the Université Paris Descartes and Assistance Publique Hôpitaux de Paris (AP-HP) in order to isolate cancer cells from blood without loss and identify them through a diagnostic cytopathology-based approach. Operation A 1-ml sample of blood will typically contain 5 to 10 million leukocytes, 5 billion erythrocytes, and a small number of circulating rare cells, including:  non-tumor cells such as epithelial-normal cells, epithelial-atypical cells, endothelial vells and stem cells;  physiological state-dependent cells such as fetal cells in pregnant and ex-pregnant women;  circulating tumor cells (CTCs) which are of diagnostic value in diagnosing various cancers.
